This scenario is observed in relapsing-remitting (RR) MS, the most common disease phenotype; in these patients B lymphocytes produce augmented quantities of LT and TNFα and reduced amounts of IL-10 in response to polyclonal stimuli and myelin antigens9, 14, 15. This evidence concerns the gene LTA and myeloid sarcoma.